Cerus Corp (CERS) stock

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value

$1.94−0.18 (-8.49%)

Close on Nov 12, 2026Market cap $390.96MP/E –Yield –

Cerus total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2010 it was $4.88M.

Period	Period end	Value	Change
FY2010	Dec 31, 2010	$4.88M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CERS.

Operating margin-1.0% · median -8.3%

Net margin-2.9% · median -6.9%

Advertisement
300 × 250

See a number that looks wrong?